Profile

Carlos Blanco

Location: Europe

Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders.

NUMBER

#676

Xs

18

Investments

46

Exits

27
Photo by areteindex.com
Unicorns
Overview
About Carlos Blanco
Number of Portfolio Companies 1
Location Europe

Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders.
His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders
Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute. He is a graduate of Universidad Autonoma de Madrid (Spain) and completed his psychiatry residency at Columbia University, where he also completed a research fellowship. Dr. Blanco has authored over 200 peer-reviewed publications.

No data.

Company name
ENTRY ROUND
VALUATION at entry ($M)
Xs
VALUATION 
Glovo
Seed
$6M
416,67
$2 500M

No data.

2024